- Gainers: Longeveron (NASDAQ:LGVN) +141%.
- Biofrontera (NASDAQ:BFRI) +96%.
- Palatin Technologies (NYSE:PTN) +44%.
- Ocuphire Pharma (NASDAQ:OCUP) +27%.
- Femasys (NASDAQ:FEMY) +25%.
- Losers: Qualigen Therapeutics (NASDAQ:QLGN) -39%.
- Vallon Pharmaceuticals (NASDAQ:VLON) -33%.
- Pasithea Therapeutics (NASDAQ:KTTA) -31%.
- Nordstrom (NYSE:JWN) -29%.
- Aptevo Therapeutics (NASDAQ:APVO)-28%.